To verify these statements, we used PTC-209 (BMI1 Polycomb Ring Finger Oncogene (BMI1) inhibitor) that we recently demonstrated to inhibit clonogenic growth in biliary tract cancer cells [6]. Here, BMI1 is linked to biliary tract cancer.